Variant report

Variant	esv16148
Chromosome Location	chr16:81246128-81252840
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:16)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:16 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:81247068..81250020-chr16:81347732..81349543,2	MCF-7	breast:
2	chr16:81247005..81248627-chr16:81352449..81354700,2	MCF-7	breast:
3	chr16:81172576..81173403-chr16:81248138..81248840,3	MCF-7	breast:
4	chr16:81245699..81248674-chr16:81249555..81252970,3	MCF-7	breast:
5	chr16:81241227..81242898-chr16:81245721..81248177,2	K562	blood:
6	chr16:81245699..81248674-chr16:81249555..81252970,3	MCF-7	breast:
7	chr16:81238218..81239252-chr16:81247860..81248811,3	MCF-7	breast:
8	chr16:81248661..81251389-chr16:81251410..81253409,3	K562	blood:
9	chr16:80957573..80958407-chr16:81248225..81248964,2	MCF-7	breast:
10	chr16:81248097..81248854-chr4:25989659..25990237,2	MCF-7	breast:
11	chr16:81241192..81243910-chr16:81245039..81247038,2	K562	blood:
12	chr16:81248661..81251389-chr16:81251410..81253409,3	K562	blood:
13	chr16:81069305..81071127-chr16:81245572..81248364,2	MCF-7	breast:
14	chr16:81237375..81239298-chr16:81246693..81248653,2	K562	blood:
15	chr16:81068795..81069630-chr16:81248235..81248808,3	MCF-7	breast:
16	chr16:81242972..81244924-chr16:81246844..81249498,3	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000261609	chromatin interactions
ENSG00000166454	chromatin interactions
ENSG00000260213	chromatin interactions

Extended variants
information (count: 465 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:465 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs201455992	chr16:81246145-81246146	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs545855773	chr16:81246149-81246150	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs550397305	chr16:81246165-81246166	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs72831366	chr16:81246167-81246168	Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs538714549	chr16:81246179-81246180	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs10541678	chr16:81246180-81246181	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs10585525	chr16:81246187-81246188	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs371961073	chr16:81246203-81246204	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs192886056	chr16:81246218-81246219	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs540438113	chr16:81246224-81246225	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs565642364	chr16:81246234-81246235	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs6564849	chr16:81246238-81246239	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs185075743	chr16:81246306-81246307	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs8058156	chr16:81246311-81246312	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs530576322	chr16:81246317-81246318	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs550800712	chr16:81246327-81246328	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs536994616	chr16:81246333-81246334	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs144584510	chr16:81246334-81246335	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs113411658	chr16:81246371-81246372	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs545461495	chr16:81246377-81246378	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs560401582	chr16:81246402-81246403	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs572368144	chr16:81246409-81246410	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs8056434	chr16:81246418-81246419	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs147882346	chr16:81246434-81246435	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs116117576	chr16:81246457-81246458	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs550531348	chr16:81246464-81246465	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs12931041	chr16:81246489-81246490	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs8058385	chr16:81246490-81246491	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs369743206	chr16:81246509-81246510	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs547436587	chr16:81246547-81246548	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs565647916	chr16:81246550-81246551	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs140560464	chr16:81246568-81246569	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs117378964	chr16:81246590-81246591	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs144525391	chr16:81246623-81246624	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs536930744	chr16:81246643-81246644	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs566448462	chr16:81246666-81246667	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs558452083	chr16:81246670-81246671	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs192787758	chr16:81246686-81246687	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs115465483	chr16:81246689-81246690	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs79524483	chr16:81246690-81246691	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs9921745	chr16:81246725-81246726	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs9928711	chr16:81246729-81246730	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs543185968	chr16:81246736-81246737	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs554989253	chr16:81246754-81246755	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs576537670	chr16:81246760-81246761	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs151232108	chr16:81246766-81246767	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs12918929	chr16:81246771-81246772	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs8056967	chr16:81246777-81246778	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs575247134	chr16:81246791-81246792	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs373794127	chr16:81246801-81246802	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:70)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
small cell lung cancer	20016488	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	18438408	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Autism	21865298	CNVD
Myelofibrosis	22110671	CNVD
Non-small cell lung cancer	21829676	CNVD
Neuroblastoma	18923524	CNVD
Lung squamous cell carcinoma	22363434	CNVD
Obesity	20622171	CNVD
Cancer	20164920	CNVD
Chronic lymphocytic leukemia	22228453	CNVD

Chromatin state (count:25 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:81215000-81254600	Weak transcription	Right Atrium	heart
2	chr16:81244800-81246200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr16:81246200-81246600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr16:81246200-81246800	Enhancers	Breast Myoepithelial Primary Cells	Breast
5	chr16:81246400-81246600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
6	chr16:81246400-81246600	Bivalent Enhancer	Brain Hippocampus Middle	brain
7	chr16:81246600-81246800	Bivalent Enhancer	Fetal Muscle Leg	muscle
8	chr16:81246600-81247000	Enhancers	Brain Anterior Caudate	brain
9	chr16:81246600-81247000	Enhancers	Brain Hippocampus Middle	brain
10	chr16:81246600-81248600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr16:81246800-81247200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr16:81247000-81248400	Weak transcription	Brain Anterior Caudate	brain
13	chr16:81248000-81248400	Bivalent Enhancer	HepG2	liver
14	chr16:81248200-81248600	Enhancers	A549	lung
15	chr16:81248200-81248800	Bivalent Enhancer	Placenta	Placenta
16	chr16:81248400-81248600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr16:81248400-81248600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr16:81248400-81248600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
19	chr16:81248400-81248600	Flanking Bivalent TSS/Enh	K562	blood
20	chr16:81248400-81248800	Enhancers	Brain Anterior Caudate	brain
21	chr16:81248400-81248800	Flanking Bivalent TSS/Enh	HepG2	liver
22	chr16:81248600-81248800	Enhancers	Gastric	stomach
23	chr16:81248600-81249000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr16:81248600-81253800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
25	chr16:81249000-81257200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links